Intellia Therapeutics Inc (NTLA) Directors and Executive Officers

Officers & Directors

Fred Cohen
Director

Glenn Goddard
Executive Vice President, Chief Financial Officer

John M. Leonard, M.D.
President and Chief Executive Officer

Frank Verwiel
Director

Georgia Keresty
Director

Muna Bhanji
Director

Bill Chase
Director

Jesse Goodman
Director ,

Intellia Therapeutics Inc currently has 377 employees.

News about Intellia Therapeutics Inc Key Personnel

Intellia Therapeutics Charts Ambitious Course for 2025: Prioritizing Late-Stage Programs and Strengthening Talent for CRISPR Innovation

Intellia Therapeutics Charts Ambitious Course for 2025: Prioritizing Late-Stage Programs and Strengthening Talent for CRISPR InnovationIn a bold move signaling its commitment to advancing groundbreaking gene editing technologies, Intellia Therapeutics, Inc. (NASDAQ: NTLA), a pioneer in CRISPR-based therapies, has unveiled its strategic priorities and key anticipated milestones for 2025. This announcement, made on January 9, 2025, focuses particularly on the company s late-stage programs, NTLA-2002 and Nexiguran Ziclumeran (nex-z), marking a pivotal moment in its quest to revolutionize healthcare for patients globally.The firm s renewed focus on these advanced programs reflects an understanding of the pressin...